Single-dose study in patients [Design Issues]

posted by dshah  – India, 2023-12-11 11:44 (510 d 00:18 ago) – Posting: # 23792
Views: 2,430

Hi Brus!

❝ When you need to perform the study in patients due to tolerability/safety reasons, How do you perform the washout period in patients? (Between periods and before period 1 to avoid pre-dose concentrations in both periods).


Generally the patient study is required to be performed for stabilized patient. How can treatment be discontinued in patient?

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
79 visitors (0 registered, 79 guests [including 7 identified bots]).
Forum time: 13:03 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5